{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:46:28Z","timestamp":1779227188054,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.eclinm.2023.101940","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:55:59Z","timestamp":1681710959000},"page":"101940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study"],"prefix":"10.1016","volume":"59","author":[{"given":"Michael","family":"Haude","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Wlodarczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 J.","family":"van der Schaaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4959-7293","authenticated-orcid":false,"given":"Jan","family":"Torzewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Ferdinande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Escaned","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan F.","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8301-4517","authenticated-orcid":false,"given":"Johan","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Toelg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Wiemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"Olivecrona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Vermeersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2023.101940_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.carrev.2021.02.003","article-title":"SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice","volume":"34","author":"Galli","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.eclinm.2023.101940_bib2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"14","author":"Neumann","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.eclinm.2023.101940_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","article-title":"Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial","volume":"387","author":"Haude","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2023.101940_bib4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.carrev.2019.02.003","article-title":"Magnesium 2000 postmarket evaluation: guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffold","volume":"20","author":"Wlodarczak","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.eclinm.2023.101940_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.carrev.2022.01.020","article-title":"Sustained safety and efficacy of magnesium reabsorbable scaffold. 2-year follow-up analysis from first Magmaris multicenter Italian registry","volume":"41","author":"Galli","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.eclinm.2023.101940_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5223317","article-title":"Magnesium bioresorbable scaffold (BRS) Magmaris vs biodegradable polymer DES ultimaster in NSTE-ACS population-12-month clinical outcome","author":"Rola","year":"2022","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.eclinm.2023.101940_bib7","article-title":"BIOSOLVE-IV-registry: safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients","author":"Verheye","year":"2020","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.eclinm.2023.101940_bib8","first-page":"E502","article-title":"Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III","volume":"92","author":"Haude","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.eclinm.2023.101940_bib9","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.110.970772","article-title":"Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes","volume":"122","author":"Serruys","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.eclinm.2023.101940_bib10","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/eurheartj\/ehv203","article-title":"Report of a European society of Cardiology-European association of percutaneous cardiovascular interventions task force on the evaluation of coronary stents in europe: executive summary","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eclinm.2023.101940_bib11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4244\/EIJV12I7A137","article-title":"Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016","volume":"12","author":"Fajadet","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.eclinm.2023.101940_bib12","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.eclinm.2023.101940_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4244\/EIJV5I7A146","article-title":"Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies","volume":"5","author":"Vranckx","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.eclinm.2023.101940_bib14","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/eurheartj\/ehy223","article-title":"Standardized end point definitions for coronary intervention trials: the academic Research consortium-2 consensus document","volume":"39","author":"Garcia-Garcia","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eclinm.2023.101940_bib31","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(07)60853-8","article-title":"Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial","volume":"369","author":"Erbel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2023.101940_bib19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)61765-6","article-title":"Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial","volume":"381","author":"Haude","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2023.101940_bib15","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.carrev.2020.04.006","article-title":"Sustained safety and performance of the second-generation sirolimus-eluting absorbable metal scaffold: pooled outcomes of the BIOSOLVE-II and -iii trials at 3 years","volume":"21","author":"Haude","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.eclinm.2023.101940_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.carrev.2021.09.012","article-title":"The resorbable magnesium scaffold Magmaris in acute coronary syndrome: an appraisal of evidence and user group guidance","volume":"39","author":"Bennett","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.eclinm.2023.101940_bib17","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jcin.2017.07.033","article-title":"6-Month clinical and angiographic outcomes of a novel radiopaque sirolimus-eluting bioresorbable vascular scaffold: the FANTOM II study","volume":"10","author":"Abizaid","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.eclinm.2023.101940_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4244\/EIJ-D-19-00324","article-title":"Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial","volume":"15","author":"Seth","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.eclinm.2023.101940_bib20","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.4244\/EIJ-D-15-00371","article-title":"Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial","volume":"12","author":"Haude","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.eclinm.2023.101940_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcin.2013.07.007","article-title":"A\u00a0next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results","volume":"7","author":"Verheye","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.eclinm.2023.101940_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007283","article-title":"Clinical and angiographic outcomes with a novel radiopaque sirolimus-eluting bioresorbable vascular scaffold","volume":"12","author":"Chevalier","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.eclinm.2023.101940_bib24","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/eurheartj\/ehy436","article-title":"Angiographic late lumen loss revisited: impact on long-term target lesion revascularization","volume":"39","author":"Asano","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eclinm.2023.101940_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10554-011-9829-y","article-title":"Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT","volume":"28","author":"Guti\u00e9rrez-Chico","year":"2012","journal-title":"Int J Cardiovasc Imag"},{"key":"10.1016\/j.eclinm.2023.101940_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s12928-022-00842-6","article-title":"Preferable vascular healing of ultrathin strut biodegradable-polymer sirolimus-eluting stents in patients with acute coronary syndrome","author":"Kawamura","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.eclinm.2023.101940_bib27","first-page":"575","article-title":"The relationship between coronary stent strut thickness and the incidences of clinical outcomes after drug-eluting stent implantation: a systematic review and meta-regression analysis","volume":"99","author":"Saito","year":"2022","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.eclinm.2023.101940_bib28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(17)31470-8","article-title":"2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy","volume":"390","author":"Ali","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2023.101940_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2021.05.006","article-title":"Effect of procedural technique on cardiovascular outcomes following second-generation drug-eluting resorbable magnesium scaffold implantation","volume":"29","author":"Ozaki","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.eclinm.2023.101940_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.carrev.2021.07.017","article-title":"Sustained safety and performance of a second-generation sirolimus-eluting absorbable metal scaffold: long-term data of the BIOSOLVE-II first-in-man trial at 5 years","volume":"38","author":"Haude","year":"2022","journal-title":"Cardiovasc Revasc Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:21:39Z","timestamp":1762899699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":30,"alternative-id":["S2589537023001177"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101940","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101940"}}